Cytomel (Liothyronine)

Cytomel (Liothyronine Sodium): Patient-Friendly Information for Australia

Basic Product Information

Mechanism of Action

For patients:
Cytomel contains liothyronine, a man-made form of the thyroid hormone triiodothyronine (T3). Your body naturally makes T3 in the thyroid gland. This hormone controls how your body uses energy and affects every cell, helping regulate metabolism, temperature, and heart rate.

For specialists:
Liothyronine is a synthetic analogue of endogenous T3. It exerts its action by entering nuclear thyroid hormone receptors, modulating DNA transcription, and producing metabolic and developmental effects similar to natural T3. Its rapid onset and short half-life support intermittent and titratable dosing in hypothyroidism and other thyroid disorders.

Pharmacokinetics

• Absorption: Liothyronine is rapidly and almost completely absorbed from the gastrointestinal tract (approx. 95%).
• Metabolism: Largely metabolised in the liver and other tissues by deiodination, with conversion to inactive metabolites.
• Elimination: Excreted mainly via the kidneys as inactive compounds; some biliary excretion.
• Onset of Action: Effects usually begin within 2-4 hours of oral dose.
• Duration of Action: 24–48 hours, shorter than levothyroxine (T4).

Use in Everyday Life and Best Practices

Typical Conditions Treated: Hypothyroidism, congenital hypothyroidism, myxoedema coma, and some thyroid cancers. On occasion, used in combination with levothyroxine for specific patients under specialist supervision.

Typical Adult Dose: Usually 10–25 micrograms once daily; starting dose may be lower if over 60 years or with heart conditions.
How to Use:

• Take exactly as prescribed by your doctor.
• Usually taken once a day, at about the same time.
• Swallow with water—do not crush unless directed.
• Do not stop suddenly or adjust the dose without consulting a healthcare provider.
• Some people may be advised to dual-therapy (with levothyroxine) — specialist review needed.

Dosing: Morning vs Evening

• Morning Dose: Most Australian guidelines recommend dosing in the morning, ideally 30 minutes before breakfast, as it aligns with your natural hormone rhythms and improves absorption.
• Evening Dose: May be considered for shift workers or if advised by a doctor. However, taking it late at night can sometimes interfere with sleep due to its mild stimulating effect.
• Best Practice: Take at the same time every day for even hormone levels. If you miss a dose, take it when you remember unless it's almost time for your next dose—do not double up.

Taking with Food or on an Empty Stomach

• Absorption: Liothyronine is best absorbed on an empty stomach.
• Advice: Wait at least 30 minutes after taking Cytomel before eating breakfast.
• English Diet Context: Avoid taking at the same time as high-fibre, soy, or calcium-rich foods (milk, yoghurt, fortified cereal), as these can reduce absorption. If you regularly have an English or Australian breakfast with milk or tea, allow some gap.

Interaction Warnings

Indications

Dosing According to Clinical Indication

Safety Profile, Side Effects, and Warnings

While many people experience few or no side effects at the correct dose, Cytomel can sometimes cause problems, especially if the dose is too high.

If you experience chest pain, rapid heartbeat, severe headache, or signs of a severe allergic reaction (swelling, difficulty breathing, rash), stop taking Cytomel and seek urgent medical advice.

Guidelines for Proper Use

• Always take Cytomel as your doctor or pharmacist has instructed.
• Do not change your dose without speaking to your healthcare provider.
• Have regular blood tests as directed (TSH, T3, T4) to monitor your thyroid levels.
• Let all your doctors, pharmacists, and dentists know you are taking this medication, especially if being treated for heart problems or surgery.
• Keep appointments for monitoring heart health in older adults or those with heart disease.
• If you become pregnant or are breastfeeding, inform your doctor promptly.
• If you move house or are away on holidays, ensure you continue your dosing schedule and have enough medicine available.

Alternative Treatment Options

• Levothyroxine (T4, e.g., Eutroxsig, Oroxine): First-line therapy for most forms of hypothyroidism in Australia; longer acting, once-daily single dose, lower risk of overdose, subsidised by the PBS.
• Natural Desiccated Thyroid Extract (Armour Thyroid, compounded): Not commonly recommended in Australia; risk of dose inconsistencies, not PBS-subsidised.
• Combination Therapy (Liothyronine + Levothyroxine): Reserved for specialist centres and carefully selected patients; more research ongoing regarding benefit/risk.

Comparison: Levothyroxine is preferred for most people due to its safety, effectiveness, and longer action. Liothyronine may be tried if symptoms persist despite normal blood tests, always under specialist care.

Legal, Registration, and Reimbursement Status in Australia

• Liothyronine (Cytomel, Tertroxin) is registered with the Therapeutic Goods Administration (TGA, Australia).
• It is a Schedule 4 (S4) medicine – available only with a valid prescription.
• Reimbursed under the Pharmaceutical Benefits Scheme (PBS) for certain indications; limitations may apply.
• Prescribing of Cytomel should be by a doctor familiar with thyroid disease.
• Not recommended for or subsidised in weight loss; specialist supervision for psychiatric use is required.

Latest Research and Clinical Guidance (2022–2025)

• 2022–2023 Australian Endocrine Society guidance: Liothyronine monotherapy is rarely required; combination therapy may benefit some persistent symptomatic patients but carries increased risk of overtreatment and side effects.
• 2022 BMJ and Lancet reviews: Current evidence does not routinely support combined T3 and T4 use in most adults with hypothyroidism. Careful case selection advised.
• 2024 NICE Guidelines (UK, relevant to AU): T3 can play a role in those with symptoms despite normal tests on T4, after exclusion of other conditions.
• Ongoing studies: Further research underway in persistent depressive illness (T3 augmentation) and in selected "non-responder" hypothyroid cases.

Key message: Only specialist physicians should supervise Cytomel use, especially for non-standard indications, due to potential risks.

Availability and Delivery (Australia)

Frequently Asked Questions (FAQ)

• Can I switch from levothyroxine to Cytomel on my own?
  No. Switching should only be done under strict medical supervision, usually by an endocrinologist, and may involve careful testing and dose adjustment.
• What if I miss a dose?
  Take it as soon as you remember, unless it’s close to your next scheduled dose – then skip the missed dose. Do not double dose. Consistency is important for best results.
• Is Cytomel safe during pregnancy or breast-feeding?
  Generally, levothyroxine is preferred in pregnancy in Australia. If you become pregnant or breastfeed while on Cytomel, inform your doctor. Adjustments may be needed to protect your baby's health.
• Are there long-term risks?
  When taken as prescribed and monitored, serious long-term risks are rare. Overuse can increase risk of heart issues, bone thinning, and other complications.
• Can I take it with other medicines?
  Always discuss all your medications with your doctor and pharmacist, as many medicines (see interactions section) can affect how Cytomel works.